Efficacy and safety of Shexiang Baoxin pill(MUSKARDIA)in patients with stable coronary artery disease:a multicenter,double-blind,placebo-controlled phase Ⅳ randomized clinical trialOACSCDCSTPCD
Efficacy and safety of Shexiang Baoxin pill(MUSKARDIA)in patients with stable coronary artery disease:a multicenter,double-blind,placebo-controlled phase Ⅳ randomized clinical trial
Jun-Bo Ge;Ying-Wu Liu;Sheng-Huang Wang;Sheng-Hu He;Ping Yang;Jie Wu;Feng Lu;Zi-Shan Hou;Wei-Hu Fan;Jing-Min Zhou;Hai-Ming Shi;Fu-Sui Ji;Yang Wu;Yu-Lan Zhao;Jun Qian;Yuan-Zhe Jin
Department of Cardiology,Zhongshan Hospital,Fudan University,Shanghai 200032,ChinaDepartment of Cardiology,Tianjin Third Central Hospital,Tianjin 300170,ChinaDepartment of Cardiology,Ningbo First Hospital,Ningbo,Zhejiang 315010,ChinaDepartment of Cardiology,Northern Jiangsu People's Hospital,Yangzhou,Jiangsu 210036,ChinaDepartment of Cardiology,China-Japan Union Hospital of Jilin University,Changchun,Jilin 130031,ChinaDepartment of Cardiology,The First Affiliated Hospital of University of South China,Hengyang,Hunan 421000,ChinaDepartment of Cardiology,The Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Jinan,Shandong 250355,ChinaDepartment of Cardiology,Linyi People's Hospital,Linyi,Shandong 276000,ChinaDepartment of Cardiology,Huashan Hospital,Fudan University,Shanghai 200040,ChinaDepartment of Cardiology,Zhongshan Hospital,Fudan University,Shanghai 200032,ChinaDepartment of Cardiology,Huashan Hospital,Fudan University,Shanghai 200040,ChinaDepartment of Cardiology,Beijing Hospital of the Ministry of Health,Beijing 100730,ChinaDepartment of Cardiology,Dongfang Hospital Affiliated to Beijing University of Chinese Medicine,Beijing 100078,ChinaDepartment of Cardiology,The Second Affiliated Hospital of Zhengzhou University,Zhengzhou,Henan 450000,ChinaDepartment of Cardiology,The Center Hospital of Ma'anshan,Ma'anshan,Anhui 243000,ChinaDepartment of Cardiology,The Fourth Affiliated Hospital of China Medical University,Shenyang,Liaoning 110032,China
MUSKARDIAStable coronary artery diseaseAnginaMajor adverse cardiovascular event
MUSKARDIAStable coronary artery diseaseAnginaMajor adverse cardiovascular event
《中华医学杂志（英文版）》 2021 (2)
185-192,8
This study was funded by the Shanghai Science and Technology Committee and Shanghai Hutchison Pharmaceuticals Company.